Genotypic and Phenotypic Properties of Cattle-Associated Campylobacter and Their Implications to Public Health in the USA by Sanad, Yasser M. et al.
Genotypic and Phenotypic Properties of Cattle-
Associated Campylobacter and Their Implications to
Public Health in the USA
Yasser M. Sanad
1,2, Issmat I. Kassem
1, Melanie Abley
2, Wondwossen Gebreyes
2, Jeffrey T. LeJeune
1,2,
Gireesh Rajashekara
1,2*
1Food Animal Health Research Program, Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, Ohio, United States of America,
2Department of Veterinary Preventive Medicine, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States of America
Abstract
Since cattle are a major source of food and the cattle industry engages people from farms to processing plants and meat
markets, it is conceivable that beef-products contaminated with Campylobacter spp. would pose a significant public health
concern. To better understand the epidemiology of cattle-associated Campylobacter spp. in the USA, we characterized the
prevalence, genotypic and phenotypic properties of these pathogens. Campylobacter were detected in 181 (19.2%) out of
944 fecal samples. Specifically, 71 C. jejuni, 132 C. coli, and 10 other Campylobacter spp. were identified. The prevalence of
Campylobacter varied regionally and was significantly (P,0.05) higher in fecal samples collected from the South (32.8%) as
compared to those from the North (14.8%), Midwest (15.83%), and East (12%). Pulsed Field Gel Electrophoresis (PFGE)
analysis showed that C. jejuni and C. coli isolates were genotypically diverse and certain genotypes were shared across two
or more of the geographic locations. In addition, 13 new C. jejuni and two C. coli sequence types (STs) were detected by
Multi Locus Sequence Typing (MLST). C. jejuni associated with clinically human health important sequence type, ST-61 which
was not previously reported in the USA, was identified in the present study. Most frequently observed clonal complexes (CC)
were CC ST-21, CC ST-42, and CC ST-61, which are also common in humans. Further, the cattle associated C. jejuni strains
showed varying invasion and intracellular survival capacity; however, C. coli strains showed a lower invasion and intracellular
survival potential compared to C. jejuni strains. Furthermore, many cattle associated Campylobacter isolates showed
resistance to several antimicrobials including ciprofloxacin, erythromycin, and gentamicin. Taken together, our results
highlight the importance of cattle as a potential reservoir for clinically important Campylobacter.
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Introduction
Campylobacteriosis is estimated to affect over one million
individuals in the United States annually, with symptoms ranging
from mild diarrhea to more serious neuropathies [1]. Of major
concern are C. jejuni, a species responsible for the majority of
human campylobacteriosis, and C. coli, which has been exhibiting
increased resistance to antimicrobials [2,3]. Both C. jejuni and C.
coli can readily and asymptomatically colonize major food-animals
such as poultry and cattle, subsequently contaminating foods of
animal origin including meats and dairy products [4]. Therefore,
both species highlight the potential public health impact of
Campylobacter contamination of food animals.
Although it is known that chickens constitute a major reservoir for
Campylobacter spp., the occurrence of these pathogens in other food
animals such as cattle and its potential impact on human health
remain largely uncharacterized. The latter can be partially attributed
to the sporadic nature of Campylobacter infections and difficulties in
isolating these fastidious pathogens. However, since cattle are a major
source of food and the multi-faceted cattle industry engages people
from farms to processing plants and meat markets, it is conceivable
that both live cattle and contaminated cattle products could
contribute significantly to Campylobacter infections in humans.
Furthermore, cattle-associated Campylobacter also pose an additional
indirect public health risk [5,6]. For example, contamination of
surface and ground water may occur with waste run-off from cattle
farming and processing operations. Thus, it is important to further
investigate the epidemiology of Campylobacter in the cattle population
in order to assess associated risks to public health.
Recent studies have shown that the contributions of non-poultry
associated Campylobacter to human infections were considerable and
warrant investigation [7,8]. For example, evidence collected using
Multilocus Sequence Typing (MLST) showed that cases of human
Campylobacter infections in Finland could be attributed equally to
cattle and poultry [9]. Moreover, another study reported that
cattle were the source of human infections in 35% of the cases
examined in Lancashire, England [8]. This is not surprising since
up to 80% of cattle herds and 40–60% of the individual animals
shed Campylobacter [10,11,12]. Consequently, the role of cattle as
reservoirs for these pathogens might be important for understand-
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particularly in the US, the prevalence of Campylobacter in cattle,
their characteristics and relationship to isolates from humans have
not been extensively described in the peer reviewed literature.
Host cell invasion and intracellular survival and resistance to
antibiotics are important characteristics that affect Campylobacter
infectionsinhumans.However,thepotentialrole oftheseproperties
in facilitating human infections with Campylobacter isolated from
cattle is not clear. Although epidemiological studies deploy typing
analysis to glean information about the relationships between cattle-
associated Campylobacter and clinically-important human isolates, the
capability of cattle-associated Campylobacter to invade and persist in
the human host might require further assessment, especially when
previously unknown sequence types are identified. This also applies
to antimicrobial resistance properties, which have been posing a
serious concern in Campylobacter collected from animal hosts along
with the possibility of the transmission of these isolates to humans
through the food chain. Therefore, epidemiological studies
concerning cattle-associated Campylobacter would gain from attempts
to amend molecular typing analysis with in vitro invasion studies
using human intestinal cell lines and phenotypic assays for
determining antibiotic resistance.
Since molecular typing data of cattle-associated Campylobacter in
the United States are limited and little is known about their impact
on human health, it is important to adopt a multiphasic approach to
characterize cattle-associated Campylobacter by using a combination
of molecular typing and in vitro assays. Therefore, in this study, we
determined the genotypes of C. jejuni and C. coli isolated from cattle
slaughtered for meat purpose in different geographical locations in
the U.S. and investigated their antimicrobial susceptibility profiles
as well as virulence associated phenotypes such as their potential for
invasion and persistence in human intestinal epithelial cells.
Materials and Methods
Distribution of sampling sites and collection and
processing of fecal samples from beef cattle
A total of 944 fresh fecal samples (10 g each) were collected
during the summer and early fall of 2008 from cattle presented to
slaughter which included both feed-lot (n=482) as well as mature
cows and bulls (n=462) culled from milking and breeding herds
(Table 1). The samples were collected from colon on the conveyer
belt during the normal harvest process from slaughtered cattle. To
account for potential spatial heterogeneity between different beef
processing plants, sampling efforts included seven plants that were
distributed across four major geographical locations [North (N),
East (E), Midwest (M), and South (S)] in the U.S. The time interval
of sample collection per plant spanned two consecutive days and
was divided into four periods during which at least four different
lots of cattle were sampled in order to capture the genetic diversity
of cattle-associated Campylobacter. To further limit sampling bias,
the number of samples collected per plant was calculated in terms
of the total number of animals expected for slaughter on each day,
and a statistically calculated sample size to detect at least a single
sequence type of Campylobacter should it be present in each group of
animals at a prevalence of greater than 2.5% with a confidence of
95%. Samples were stored on ice immediately after collection and
shipped overnight to the laboratory for Campylobacter isolation.
Isolation and identification of Campylobacter species
from fecal samples
To isolate Campylobacter spp., 1 g of each fecal sample was
enriched in Preston broth for 48 h at 42uC under microaerobic
conditions (5% O2, 10% CO2,a n d8 5 %N 2) [13]. From the
enrichments, an inoculum (100 ml) was spread onto modified
Cefoperazone Charcoal Deoxycholate Agar (mCCDA) plates,
which were then incubated for an additional 48 h at 42uC under
microaerobic conditions [14]. Three to five colonies suspected as
Campylobacter were selected from each plate and sub-cultured onto
Muller-Hinton agar plates, after which DNA was extracted from
each isolate using the Genomic DNA Purification Kit (Epicenter,
Madison, WI) as described by the manufacturer. The DNA was
then quantified using the NanoDrop 1000 Spectrophotometer
V3.7.1 (Fisher Scientific, Pittsburgh, PA) and subjected to species-
specific PCR analysis to confirm the identity of the isolates as
described elsewhere [15]. PCR analysis targeted a 16S rRNA gene
fragment (F) 59-ATCTAATGGCTTAACCATTAAAC-39 and (R)
59-GGACGGTAACTAGTTTAGTATT-39, mapA, (F) 59-CTA-
TTTTATTTTTGAGTGCTTGTG-39 and (R) 59-GCTTTAT-
TTGCCATTTGTTTTATTA-39 and ceuE, (F) 59ATTTGAAA-
ATTGCTCCAACTATG-39 and (R) 59-TGATTTTATTATTT-
GTAGCAGCG-39 which indicated the specific detection of
Campylobacter spp., C. jejuni,a n dC. coli, respectively [16,17]. All
PCR products were resolved on a 1.5% agarose gel containing
0.5 mg/ml of ethidium bromide. The size of the PCR products was
determined using a 1 Kb DNA ladder and detection was confirmed
by comparison to PCR products generated from C. jejuni 81–176
(wild-type strain) and C. coli (ATCC 33559), which were used as
positive controls in all PCR analysis. Negative controls (reactions
with no DNA templates) were included in all PCR analyses to
ensure specific product amplification.
Pulsed Field Gel Electrophoresis (PFGE) of Campylobacter
isolates
To determine their genotypic relatedness, the Campylobacter
isolated from fecal samples were analyzed using PFGE analysis as
describedinRibotetal.[18].Briefly,C.jejuniand C.coliisolateswere
harvested from MH agar plates and suspended to an OD610 of 1.4
in 1X PBS. To prepare agarose plugs, OD adjusted suspensions
were gently mixed with 1% SeaKem Gold agarose (SKG, Fisher
scientific, Pittsburgh, PA) that was pre-melted in TE (10 mM Tris,
1 mM EDTA, pH 8.0). The plugs were then incubated with
shaking (200 rpm) in lysis buffer [50 mM Tris, 50 mM EDTA
(pH 8.0), 1% sarcosine, 0.1 mg ml
21 of proteinase K] for 1 h at
55uC. After lysis the plugs were washed four times and suspended in
5 ml of fresh TE. The plugs were then sliced and digested overnight
with SmaI at room temperature. The digested slices were loaded
onto a 1% SKG agarose gel and DNA fragments were separated by
electrophoresis for 20 h using the CHEF Mapper system (Bio-Rad,
Hercules, CA) followed by post staining with ethidium bromide.
The resulting PFGE patterns were documented and analyzed using
the BioNumerics 5.1 software (Applied Maths Inc, Austin, TX).
Similarity and clustering analysis of the PFGE patterns were
performed using the Dice Coefficient and the unweighted pair-
group method with arithmetic averages (UPGMA) with optimiza-
tion of 1% and position tolerance of 1.5% [7], respectively. The
PFGE analysis was also performed on C. jejuni 81–176 and C. coli
(ATCC 33559), which were used as controls for facilitating gel to gel
comparison. Furthermore, Lambda Ladder PFG Marker (50–
1,000 kb, New England BioLabs, Ipswich, MA) was used as a
molecular marker. A cut-off similarity value of 75%, was used to
determine the sub-clusters of macro restriction profiles (MRPs).
Determining the antimicrobial-resistance properties of
the Campylobacter isolates
Minimal inhibitory concentrations (MIC) for C. jejuni and C. coli
isolates were determined using commercially available 96-well
Cattle-Associated Campylobacter in the USA
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Diagnostic Systems Inc., Cleveland, OH, USA). These Sensititre
Campy plates were used as described by the manufacturer and
include Campylobacter-relevant antimicrobials such as azithromycin
(AZI) (MIC for a resistant Campylobacter isolate: $8 mgm l
21);
ciprofloxacin (CIP) (MIC: $4 mgm l
21); clindamycin (CLI) (MIC:
$8 mgm l
21); erythromycin (ERY) (MIC: $32 mgm l
21); genta-
micin (GEN) (MIC: $8 mgm l
21); nalidixic acid (NAL) (MIC:
$64 mgm l
21); telithromycin (TEL) (MIC: $8 mgm l
21); florfeni-
col (FEN) (MIC: $8 mgm l
21); and tetracycline (TET) (MIC:
$16 mgm l
21). Campylobacter isolates were grown to mid-log phase
and then suspended in Mueller-Hinton broth to achieve an OD600
of 0.05. For each isolate, one hundred microliter of the suspension
were transferred to each well in the Sensititre Campy plates,
including a control well that did not contain any antibiotics, while
C. jejuni 81–176 and C. coli (ATCC 33559) were used for quality
control. The plates were then incubated under microaerobic
conditions at 42uC for 24 h after which the minimum inhibitory
concentration (MIC) was measured. The MIC for each antibiotic
was defined as the absence of bacterial growth in the well with the
lowest concentration of the antibiotic and susceptibility was
interpreted according to the Clinical and Laboratory Standards
Institute (CLSI) [19].
Multilocus sequence typing (MLST) of Campylobacter
isolates
To investigate the clonality of the Campylobacter isolates and to
assess similarity to strains associated with human infections, MLST
analysis was performed on a total of 112 isolates (62 C. jejuni and 50
C. coli). Nine C. jejuni isolates were not typed because either they
yielded incomplete profiles or last culturability upon storage.
However, since the C. coli isolates showed limited genetic diversity
using MLST, the tested number of isolates (n=50) was considered
adequate to meet the objectives of this study. These isolates were
selected to be representative of different PFGE clusters. MLST
analysis was conducted as described by Dingle et al. [20]. Briefly,
loci from seven housekeeping genes (aspA, glnA, gltA, glyA, pgm, tkt,
and uncA) were amplified using gene specific primers by PCR and
anticipated sizes of the amplicons were confirmed by agarose gel
electrophoresis. The Campylobacter MLST oligonucleotides [20]
were obtained from Integrated DNA Technologies (Coralville, IA).
PCR products were purified (QIA quick 96 PCR purification kit,
QIAGEN, Valencia, CA), sequenced in both directions as
described previously [21], and, forward and reverse sequences
were then aligned using ClustalW (www.ebi.ac.uk/clustalw).
Allelic profiles were determined by performing BLAST analysis
using the single-locus query function, while sequence types (STs)
were assigned using the allelic profile query function available in
the MLST Campylobacter database (http://pubmlst.org/campylo-
bacter/). STs were then traced to their respective clonal complexes
using BURST at http://pubmlst.org/.
Invasion and Intracellular survival potential of the
Campylobacter isolates in INT407 cells
Representative C. jejuni (n=19) and C. coli (n=12) that belonged
to clonal complexes associated with human infections as well
unassigned clonal complexes including the newly identified STs
were further tested for their virulence associated phenotypes by
assessing their ability to invade and survive within human
intestinal epithelial cells. The invasion studies were conducted as
described in Konkel et al. [22] and Prasad et al. [23]. Briefly, 10
5
cells ml
21 of INT407 (human embryonic intestine, ATCC CCL 6)
were seeded into each well of a 24-well tissue culture plates after
suspension in Eagle’s Minimum Essential Medium (MEM, Fisher
scientific, Pittsburgh, PA) supplemented with 10% fetal bovine
serum (FBS, Fisher scientific, Pittsburgh, PA). The plates were
then incubated at 37uC in a humidified incubator with 5% CO2
until semi-confluent mono-layers were obtained. In preparation
for infection with Campylobacter, the INT407 mono-layers were
washed three times and covered in MEM supplemented with 1%
FBS. Similarly, Campylobacter cultures were washed three times and
suspended in MEM supplemented with 1% FBS to obtain 10
7
bacteria ml
21. One ml of bacterial suspension was added to each
well containing the INT407 cell monolayer, achieving a 1:100
multiplicity of infection (MOI) then incubated for 3 h. After 3 h of
incubation with bacteria, cells were treated with gentamicin
(150 mg/ml) and incubated for additional 2 h. The infected mono-
layers were then washed three times with MEM, lysed using 0.1%
Triton X-100 (Fisher scientific, Pittsburgh, PA), serially diluted
(10-fold) in MEM and 100 ml of each dilution were spread on MH
agar plates. The agar plates were then incubated for 48 h at 42uC
under microaerobic conditions, after which colony forming units
(CFU) were counted to determine the number of Campylobacter that
invaded the monolayers. Each isolate was tested in duplicate per
assay, and the experiment was repeated three times on separate
occasions. C. jejuni 81–176 (highly invasive) [24], C. jejuni
NCTC11168 (poorly invasive) [24] and C. coli (ATCC 33559)
were used as controls in all invasion assays.
To assessintracellular survival [22], Campylobacter cultures and the
INT407 cells were processed as described above. However, after
treatment with gentamicin, MEM containing 3% FBS and
bacteriostatic concentration of gentamicin (10 mgm l
21) were added
to each well to allow strict quantitation of intracellular bacteria.
After further incubation at 37uC for 24 h, the monolayers were
washed three times, lysed and serially diluted in MEM as described
earlier and plated on MH agar to determine CFU of Campylobacter
surviving within the intestinal cells. In addition, we also cultured the
supernatant of gentamicin treated monolayers to ensure the quality
Table 1. Campylobacter species isolated from cattle fecal samples that were collected from four major geographical locations in
the USA.
Regions Number of samples Campylobacter prevalence/region (%) Number of C. jejuni Number of C. coli
North 210 31/210 (14.8%) 13 16
Midwest 240 38/240 (15.83%) 36 12
South 244 80/244 (32.8%) 8 83
East 250 32/250 (12%) 14 21
Total 944 181/944 (19.2%)* 71 132
*A total of 213 Campylobacter isolates occurred in 181 fecal samples including 10 Campylobacter spp. other than C. jejuni and C. coli.
doi:10.1371/journal.pone.0025778.t001
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three times on separate occasions. C. jejuni 81–176, C. jejuni
NCTC11168, and C. coli (ATCC 33559) were used as controls in
all intracellular survival assays.
Statistical analysis
A Chi square test was used to evaluate data collected from the
Campylobacter prevalence analysis. The data derived from cell
culture assays were analyzed using one-way ANOVA followed by
Tukey’s Multiple Comparison Test. A P value of ,0.05 was
considered statistically significant for all experiments. Measure-
ments expressed as mean 6 SE (standard error) were averages of
at least three replicas.
Results
Occurrence and distribution of Campylobacter spp. in
feces sampled from cattle
The occurrence and distribution of Campylobacter in cattle feces
was investigated in order to determine the role of cattle as a
potential reservoir for these bacteria. Campylobacter were detected in
181 (19.2%) out of 944 fecal samples, while a total of 213 isolates
were retrieved from the Campylobacter-positive fecal samples. The C.
jejuni and C. coli constituted the majority of the isolates and were
detected in 71 (7.5%) and 132 (14%) of the samples, respectively
(Table 1). There was no significant difference (P,0.12) in the
number of C. jejuni isolated from fecal samples obtained from;
either feed lot (6.2%) or the cull cattle (8.9%), while C. coli was
more frequently isolated from cull cattle (17%) as compared to
feed lot cattle (11%) (P,0.01). Furthermore, the occurrence of
Campylobacter in cattle feces varied according to geographic location
of the sampling sites. Specifically, Campylobacter species were
retrieved from 32.8% of the fecal samples collected from the
South, which was significantly higher (P,0.05) than those from
the North (14.8%), Midwest (15.83%), and East (12%) (Table 1).
C. jejuni and C. coli strains were genotypically diverse
across different geographic regions
PFGE analysis was performed on C. jejuni and C. coli isolated
from feces in order to determine the genetic diversity of these
bacteria and the relationship between the isolates retrieved from
different geographic locations. PFGE analysis was successfully
performed on 67 out of 71 C. jejuni, while 4 isolates could not be
typed using the aforementioned method. Regardless, analysis of
the PFGE profiles of the C. jejuni suggested that the isolates
possessed diverse genotypes, especially when comparing profiles of
isolates belonging to different geographic locations (Fig. 1A).
Furthermore, there were 7 main clusters (Fig. 1A) and by using a
cut-off similarity value of 75%, profiles of the C. jejuni were
classified to15 sub-clusters. With the exception of 4 clusters that
included isolates that were collected from 2 to 3 different
geographic locations, C. jejuni profiles were mostly found to form
geographically homogenous groupings. For example, one cluster
was composed of three isolates collected from the East, the
Midwest, and the South, respectively, while others included 4
isolates, 3 of which were isolated from the Midwest and one from
the South (see arrows in Fig. 1A). Overall, it was interesting to
observe that profiles of the isolates from the North did not group
with those collected from the East and the South.
Similarly, PFGE analysis was successfully performed on 115 out
of 132 C. coliisolates,while theremainingisolatescould notbe typed
using the aforementioned method (Fig. 1B). Unlike the C. jejuni,
PFGE profiles of certain C. coli isolated from all four geographic
locations were found to share a 100% similarity. Specifically,
analysis grouped the C. coli isolates into 4 main clusters and by using
a cut-off similarity value of 75%, 21 sub-clusters were identified, 2 of
which included identical profiles (100% similar) for isolates from
different geographic locations (See arrows Fig. 1B). For example, a
cluster was composed of 5 isolates (4 from the North and 1 from the
East) that displayed identical profiles, while another cluster similarly
contained identical profiles of 4 isolates (3 from the North and 1
from the South). However, other clusters contained profiles of C. coli
isolates from different geographic locations that were not identical,
yet exhibited high similarity (between 79 to 95%) than that of the
cut-off (75%). Similar to PFGE analysis of C. jejuni, many C. coli
isolated from the same geographic location showed profiles that
tend to cluster together.
Antimicrobial susceptibility of C. jejuni and C. coli isolates
To better assess the potential public health impact of the
Campylobacter spp. associated with cattle, the isolates were assayed for
their potential to resist antibiotics that are of both clinical and
veterinary importance. Antimicrobial susceptibility was assessed on 66
(the 5 remaining isolates lost cultivability after storage) C. jejuni isolates
using commercially available Sensititre Campy plates. The C. jejuni
isolates were resistant to different antimicrobials including, ciproflox-
acin (MIC: 4–64 mgm l
21), erythromycin (MIC: 32 mgm l
21),
tetracycline (MIC: 16–64 mgm l
21), and clindamycin (MIC: 8–
16 mgm l
21) (Fig. 2A). However, resistance to tetracycline was
observed for the majority of the tested C. jejuni (72.7%), while
resistance to nalidixic acid was observed for only 27.3% of the isolates
(F i g .2 A ).Fu r t h e rm o re ,1 0( 1 5 .1 %)t e s t e dC. jejuni were resistant only to
tetracycline, while 34 (51.5%) isolates were resistant to 3 or more
antimicrobials, including ciprofloxacin, tetracycline, nalidixic acid,
erythromycin, and clindamycin. Overall, a higher percentage of C.
jejuni isolates from the South region showed decreased resistance to
most of the antimicrobials (See asterisk Table 2). The MRPs and
antimicrobial resistance profiles of the C. jejuni isolates analyzed by
MLST are summarized in Table S1.
Since, C. coli isolates belonging to different PFGE clusters were
highly similar, we tested representative isolates from each cluster
for a total of 63 isolates. Although the range of MIC to disparate
antibiotics was at instances different from those observed for C.
jejuni, the C. coli isolates also exhibited resistance to the several of
the antimicrobials tested (Fig. 2B). For example, C. coli isolates
were resistant to ciprofloxacin (MIC: 4–64 mgm l
21), erythromy-
cin (MIC: 32–64 mgm l
21), tetracycline (MIC: 16–64 mgm l
21),
and clindamycin (MIC: 16 mgm l
21) (Table 3). Furthermore,
resistance to telethromycin was observed for the majority of the
tested C. coli (66.7%), while resistance to flourofenicol was
observed for only 25.4% of the isolates (Fig. 2A). Of the 63 tested
C. coli, 3 (4.8%), 9 (14.3%) and 48 (76.2%) isolates were resistant to
only one (e.g. nalidixic acid), two (e.g. ciprofloxacin and nalidixic
acid), and three or more antimicrobials, respectively. Furthermore,
Figure 1. Dendrogram showing the Pulsed-field gel electrophoresis patterns for SmaI restricted cattle-associated C. jejuni (A) and C.
coli (B). Similarity analysis was performed using the Dice coefficient, and clustering was performed by the unweighted pair-group method with
arithmetic averages UPGMA (optimization, 1% and position tolerance, 1.5%). Clustering cut-off was 75% similarity, which was represented by dashed
line. Numbers on bootstraps represent Cophenetic correlations. N=North, S=South, M=Midwest, and E=East. Cj=C. jejuni,C C=C. coli.
doi:10.1371/journal.pone.0025778.g001
Cattle-Associated Campylobacter in the USA
PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e25778a higher percentage of C. coli isolates from the South showed
increased resistance to all the antimicrobials (Table 2).
MLST analysis identifies STs belonging to human clonal
complexes
To determine the genotypic properties of Campylobacter spp.
isolated from cattle as well as their relationship to those of human
origin, MLST analysis was performed on selected C. jejuni and C.
coli isolates. A total of 112 isolates, 62 C. jejuni and 50 C. coli that
represented the main PFGE clusters and different geographic
locations, were selected for MLST analysis. Thirteen new C. jejuni
STs were identified and designated as STs 4922 to 4932, 5447,
and 5448 (Table 3). These new STs were recognized following
query with the PubMLST database. Furthermore, three new
Figure 2. Antimicrobial resistance of Campylobacter isolated from cattle. C. jejuni (A) and C. coli (B) isolates obtained from four different
locations across the US. Percentage of isolates resistant to different antimicrobials used in this study is shown. C. jejuni 81–176 and C. coli ATCC 33559
strains were used for quality control.
doi:10.1371/journal.pone.0025778.g002
Table 2. Antimicrobials resistance of C. jejuni and C. coli isolated from four different locations.
Number of resistant isolates (%) and range of MICs in mg/ml
Isolates AZI CIP ERY GEN TET FFN NAL TEL CLI
CJ N 5(7.6%)
8–32
a
6(9.1%)
4–64
1(1.5%)
32
3(4.5%)
8–16
9(13.6%)
16–64
3(4.5%)
8–16
8(12.1%)
64
7(10.6%)
8
4(6.1%)
16
S* 0 1(1.5%)
64
0 0 2(3.0%)
16–64
0 2(3.0%)
64
00
M 6(9.1%)
8–16
4(6.1%)
16–32
4(6.1%)
32
8(12.1%)
8–16
26(39.4%)
16–64
4(6.1%)
8–16
4(6.1%)
64
9(13.6%)
8
11(16.7%)
8–16
E 7(10.6%)
8–32
4(6.1%)
16–32
3(4.5%)
32
6(9.1%)
8–16
11(16.7%)
16–64
0 4(6.1%)
64
4(6.1%)
8
6(9.1%)
8–16
CC N 0 2(3.2%)
4–16
0 1(1.6%)
8
1(1.6%)
16
0 6(9.5%)
64
4(6.3%)
8
2(3.2%)
8–16
S 10(15.9%)
8–64
24(38.1%)
8–64
10(15.9%)
32–64
13(20.6%)
8–32
20(31.7%)
16–64
10(15.9%)
8–32
23(36.5%)
64
26(41.3%)
8
16(25.4%)
8–16
M 3(4.8%)
64
2(3.2%)
8–32
2(3.2%)
32–64
4(6.3%)
8–16
3(4.8%)
16–64
0 2(3.2%)
64
5(7.9%)
8
3(4.8%)
16
E 8(12.7%)
16–64
3(4.8%)
4–8
8(12.7%)
32–64
3(4.8%)
8–16
8(12.7%)
16–32
6(9.5%)
8–64
6(9.5%)
64
7(11.1%)
8
10(15.9%)
8–16
aresistance MIC range of antimicrobials.
*decreased resistance to most of antimicrobials.
doi:10.1371/journal.pone.0025778.t002
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64) were detected for 3 STs out of 13 new C. jejuni STs. Both pgm
and tkt alleles had only a single nucleotide polymorphism, while
glyA had a two nucleotide polymorphism.
In general C. jejuni isolates showed high genetic diversity by
MLST analysis (Table 3). A total of 25 different STs were
identified. Twenty isolates with 8 STs belonged to Clonal
Complex (CC) ST-21, while 3 of these isolates were assigned to
new STs. Additional isolates (n=19) were grouped into 3 STs that
belonged to CC ST-42, while five, three, and 11 isolates were
identified as ST-459 which belonged to CC ST-42, ST-590, and
ST-1013, respectively. Finally, one isolate belonged to CC ST-45,
one belonged to CC ST-48, and 9 belonged to undefined CC
(Table 3). Interestingly, we also detected in our study three isolates
belonging to clonal complex ST-61, and two of them were
identified as ST-61, which is clinically important and has not been
reported previously in cattle in the USA according to the
PubMLST database. The most frequently observed clonal
complexes (CC) were CC ST-21, CC ST-42, and CC ST-61,
which are also common in humans. Six isolates in our collection
had incomplete allelic profiles and could not be assigned to any
ST.
In contrast to C. jejuni isolates, C. coli isolates showed very limited
diversity (Table 3). Of the 50 C. coli isolates analyzed (Table 3), a
Table 3. Distribution of multilocus sequence types among cattle C. jejuni and C. coli.
ST* C. jejuni Isolates Isolates/Region ST- CC
NEM S
590 3 0 1 2 0 ST-42
1013 11 2 0 7 2
459 5 0 0 5 0
797 7 0 1 5 1 ST-21
4924 5 0 0 3 2
2876 2 0 0 2 0
4026 2 1 0 1 0
4930 1 0 1 0 0
4922 1 0 0 1 0
4923 1 0 0 1 0
239 1 0 0 1 0
61 2 0 2 0 0 ST-61
500 1 0 0 1 0
3091 1 1 0 0 0 ST-45
3084 1 0 0 0 1 ST-48
4929 2 0 2 0 0 Unassigned
4925 1 0 0 1 0
4926 1 0 0 1 0
4927 1 1 0 0 0
4928 1 0 1 0 0
4931 1 0 0 1 0
4932 1 0 0 0 1
922 1 0 1 0 0
5447 2 0 0 2 0
5448 1 1
ST C. coli Isolates Isolates/Region ST- CC
NE M S
1068 40 8 2 7 23 ST-828
902 2 0 0 2 0
2501 2 1 0 0 1
1110 2 0 2 0 0
3866 1 0 0 0 1
5372 1 0 0 0 1
4933 1 0 0 0 1
5446 1 0 0 1 0
*Complete allelic profiles for six C.jejuni isolates could not be ascertained.
doi:10.1371/journal.pone.0025778.t003
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4933 and ST-5446. Interestingly, 40 (80%) isolates were identified
as ST-1068. Twenty three of those 40 isolates were isolated from
the South as well as 8 from the North, 7 from the Midwest and 2
from the East. Additionally, seven different STs were identified
from the remaining 10 strains that were isolated from all four
regions. Two of these isolates were identified as ST-902 (from
Midwest), while the remaining two isolates (from the North and
the South, respectively) were identified as ST-2501. Additional
isolates (n=2) were identified as ST-1110 (East), while three more
isolates were identified as ST-3866, ST-5372, and ST-4933,
respectively. Additionally, one isolate was identified as a new ST-
5446 (Midwest). All 50 C. coli isolates belonged to CC ST-828
(Table 3).
Invasion and intracellular survival potential of cattle
associated C. jejuni and C. coli
To investigate the virulence-associated potential of the cattle-
associated C. jejuni and C. coli, we tested selected isolates for their
ability to invade and survive in human INT407 intestinal epithelial
cells. C. jejuni and C. coli isolates that belonged to all the detected
CCs were selected for these assays; in addition isolates that
exhibited disparate antibiotic resistance profiles and/or originated
from different geographic locations were also included in this
analysis. All tested C. jejuni isolates (n=19) invaded INT407
(Fig. 3A); however, the invasion potential varied between isolates,
ranging from an average of 2.75610
1 to 8.0610
4 CFU ml
21
(Fig. 3A). The invasion capability of 17 of the 19 isolates tested was
significantly lower than that of the highly invasive strain C. jejuni
81–176 (P,0.01); however, 11 of these isolates invaded the
INT407 cells with higher numbers as compared to the poorly
invasive C. jejuni NCTC11168 (Fig. 3A). Furthermore, two C. jejuni
isolates Cj-M-13 and Cj-N-33 exhibited high invasion potential
that matched that of C. jejuni 81–176 (Figure 3A). Interestingly, all
tested C. jejuni isolates were capable of intracellular survival, albeit
the potential varied between isolates, ranging from an average of
8.0610
1 to 1.3610
4 CFU ml
21(Fig. 3B). Additionally, the same
aforementioned two isolates showed a significantly higher
(P,0.01) potential for intracellular survival as compared to that
of C. jejuni 81–176.
On the other hand, only nine C. coli isolates could invade the
INT407 cells with average numbers ranging between 2.75610
1
and 1.34610
4 CFU ml
21 (Fig. 4A). There was a significant
difference in the invasion capabilities between the C.coli isolates
(P,0.05). Furthermore, only seven isolates were capable of
intracellular survival (Fig. 4B). Three isolates that did not invade
were not tested for intracellular survival. In general C. coli isolates
were less invasive and displayed reduced intracellular survival
compared to C. jejuni.
Our data also show that invasive Campylobacter possessed a
variable antimicrobial phenotype that ranged from complete
susceptibility to resistance to 7 different antimicrobials (Table 4).
However, it was notable that C. jejuni isolates with high invasion
potential (Cj-M-13 and Cj-N-33) were also resistant to multiple
antimicrobials (see asterisks Table 4; Fig. 3A).
Discussion
We investigated the occurrence of two important Campylobacter
spp. (C. jejuni and C. coli) in cattle that are slaughtered for meat
production across 4 major geographic locations in the USA. This
is in contrast to previous studies of cattle-associated Campylobacter in
the USA, which have been mostly geographically confined and/or
limited to investigating the prevalence of certain species as well as
other phenotypic characteristics such as antibiotic resistance
[12,25,26]. Therefore, our approach was unique as it included
analysis of genotypic diversity and antimicrobial resistance
properties as well as attempts to understand the potential role of
cattle-associated Campylobacter in virulence related phenotypes that
might impact human health. Significantly, our findings highlight
the importance of cattle as a reservoir for genotypically diverse,
antimicrobial resistant, and potentially virulent Campylobacter in the
USA.
Although the association of Campylobacter spp. with cattle in the
USA has been investigated previously, available literature reported
differing prevalence numbers for these pathogens. For example,
Hoar et al [26] isolated Campylobacter from 5% of the fecal samples
collected from cattle, while Sato et al [27] and Gharst et al [28]
showed that these bacteria occurred in 27.9% and 23.4% of their
samples, respectively. These differences in the prevalence of cattle-
associated Campylobacter can be attributed to several factors,
including methods for isolation, sample size and type (e.g. dairy
versus feedlot), seasonal variations, and geographical location [2].
However, the latter factor, geographical location, was a prominent
difference in the aforementioned prevalence studies, which were
conducted in California, Wisconsin and Southeastern region of the
USA, respectively [26,27,28]. Since the prevalence of cattle-
associated Campylobacter in the USA seemed to vary according to
the geographic location, it was necessary in this study to investigate
this assumption as well as the overall occurrence of these bacteria
in cattle. Our results showed that the occurrence of Campylobacter in
Southern USA (prevalence of 32.8%) was significantly (P,0.05)
higher than those observed in Northern (14.8%), Midwestern
(15.83%), and Eastern (12%) locations. The precise reasons that
contribute to the observed differences in geographic distribution of
the Campylobacter are not clear. Nevertheless, previous studies have
suggested that environmental conditions such as temperature,
humidity, and sunlight might contribute to increases in human
infections with Campylobacter [29]. Subsequently, the climate might
be a driver of the relatively higher prevalence of cattle-associated
Campylobacter in the Southern USA, which is generally warmer as
compared to the other locations. Interestingly, Stanley et al. [30]
suggested that indirect-temperature dependent factors such as
migratory animals might impact the occurrence of Campylobacter in
dairy cattle. Additionally, C. coli have been previously reported to
predominantly occur in samples collected from broiler flocks
during warmer months [15]. Strikingly higher prevalence of C. coli
(83 isolates) in our samples from the South (Table 1) further
support a role for climate in affecting the geographic prevalence of
Campylobacter. Regardless, the overall prevalence of cattle-associat-
ed Campylobacter in this study was 19.2%, falling between the
percentages (0.8 to 46.7%) reported for cattle from other countries
[31]. However, it is important to note that samples in our study
were collected only over a two-day period from a limited number
of locations in each region. Furthermore, to emphasize a public
health relevance of cattle as potential reservoir for Campylobacter
(discussed below), our sampling efforts focused on the seasons that
normally witness an increase in Campylobacter incidences [8]. As
such our prevalence data don’t account for possible seasonal and
temporal variations and, from this study alone, the extent to which
differences between geographic locations contributed to Campylo-
bacter prevalence in cattle cannot be conclusively ascertained.
Nevertheless, our prevalence data provide evidence that like in
other countries cattle in the USA might constitute a considerable
reservoir for these pathogens, promoting their potential persistence
in cattle-derived products and environment, which might pose a
risk for human consumers and cattle-handlers.
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their adaptation capabilities, readily acquiring genetic material
necessary for survival and persistence [32]. High genotypic
diversity has been reported in Campylobacter isolated from humans,
chickens, sheep, pigs, and cattle [33,34,35,36]. This is important
since the genotypic diversity of these bacteria might serve as an
Figure 3. Invasion and intracellular survival of cattle C. jejuni isolates in INT407 cells. A. CFU ml
21 representing the number of the
internalized bacteria which could be retrieved after treatment of cells with gentamicin. B. Intracellular survival of C. jejuni isolates in INT407cells.
CFU ml
21 representing the numbers of internalized bacteria retrieved after 24 h of incubation following the gentamicin treatment. The INT407 were
infected with 1:100 MOI of C. jejuni strains. C. jejuni 81–176 and NCTC11168 were used as controls. The detection limit of the assay is represented by
the dashed line. Each bar represents the mean 6 SE of three independent experiments done in duplicates for each sample (P,0.01).
doi:10.1371/journal.pone.0025778.g003
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PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e25778Figure 4. Invasion and intracellular survival of cattle C. coli isolates in INT407 cells. A. CFU ml
21 representing the number of the
internalized bacteria which could be retrieved after treatment of cells with gentamicin. B. Intracellular survival of C. coli isolates in INT407cells.
CFU ml
21 representing the numbers of internalized bacteria retrieved after 24 h of incubation following the gentamicin treatment. The INT407 cells
were infected with 1:100 MOI of C. coli strains. C. coli (ATCC 33559) and C. jejuni NCTC11168 were used as controls. The detection limit of the assay is
represented by the dashed line. Each bar represents the mean 6 SE of three independent experiments done in duplicates for each sample (P,0.01).
doi:10.1371/journal.pone.0025778.g004
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the persistence of these microorganisms and their evolution [36]. As
elegantly demonstrated by Wilson et al. [36], the broiler
gastrointestinal tract constitutes such a niche, allowing multiplica-
tion of C. jejuni and enhancing its genetic diversity. Subsequently, it
was important to investigate the genetic diversity of Campylobacter in
cattle in order to assess the potential attributes of this reservoir. Our
PFGE analysis of the cattle-associated Campylobacter revealed that all
C. jejuni and C. coli isolates were generally grouped into 7 and 4
major clusters, respectively (Fig. 1). Remarkably, some C. jejuni
isolates possessed genotypes that were 100% similar on 3 different
occasions (see stars in Fig. 1A). Similarly, several C. coli exhibited
100% similar genotypes and were encountered on seven occasions
(see asterisks in Fig. 1B). Taken together, these observations confirm
a high genetic diversity within the cattle-associated C. jejuni and C.
coli isolated in the USA, which also corroborates the findings of
studies conducted on cattle in other countries, including Spain [35],
the United Kingdom [37], Denmark [38], Finland [9], and Turkey
[39]. Additionally, our PFGE analysis revealed clustering of some C.
jejuni isolates (more than 75% similarity) that originated from
different geographic locations. Likewise, some clusters included C.
coli isolates with identical genotypes originating from different
geographic locations (see arrows Fig. 1). This indicated that isolates
with identical genotypes can occur in different herds, which
highlights the possibility for certain strains to be transmitted among
disparate herds/individuals. However, the latter requires further
investigation to elucidate potential routes and mechanisms of
transmission. Our PFGE analysis shows that cattle can be
considered a potential reservoir for genetically diverse Campylobacter
that is worth investigating in order to determine its relevance to
public health in the USA.
An outstanding feature in livestock associated Campylobacter is its
ability to resist antibiotics (reviewed in Luangtongkum et al. [40],
an increasingly important emerging threat to public health [41].
Table 4. The properties of C. jejuni and C. coli isolatesthat were tested for invasion and intracellular survival in INT407 cell line.
C.jejuni Isolates Invasion
a Survival Antimicrobial Resistance Profile ST CC ST MRP cluster
Cj-M-6 Moderate High Susceptible 797 CC ST21 II
Cj-M-11 Moderate High GEN, TET, NAL 4922 CC ST21 II
Cj-M-52 Moderate High CIP, TET, TEL, CLI 4924 CC ST21 V
Cj-M-13* High High AZI, CIP, ERY, GEN, FFN, TEL, CLI 2876 CC ST21 II
Cj-N-33* High High AZI, CIP, GEN, TET, NAL, TEL, CLI 4026 CC ST21 II
Cj-M-48 Moderate High ERY, CLI 4923 CC ST21 V
Cj-M-41 Poor Poor TET, FFN, NAL 239 CC ST21 IV
Cj-E-29 Poor Moderate CIP, TET, TEL 4930 CC ST21 II
Cj-M-60 Moderate Poor TET 459 CC ST42 VII
Cj-S-14 Moderate High Susceptible 4924 CC ST21 II
Cj-E-58 Poor Moderate AZI, GEN, TET, NAL, TEL 4929 UA VI
Cj-M-63 Moderate-High High TET 4925 UA VII
Cj-M-1 Moderate High TET, TEL, CLI 4931 UA I
Cj-M-64 Moderate-High High AZI, CIP, ERY, GEN, TET, CLI 4926 UA VII
Cj-N-7 Poor Moderate-High AZI, ERY, FFN, TEL, CLI 4927 UA II
Cj-E-57 Poor Poor CIP, ERY, TET 922 UA VI
Cj-E-42 Poor Moderate CIP, GEN, TET, NAL, CLI 4928 UA IV
Cj-S-56 Moderate High TET 4932 UA V
Cj-E-45 Moderate Poor AZI, ERY, GEN, CLI 61 CC ST61 IV
C.coli Isolates Invasion Survival Antimicrobial Resistance Profile ST CC ST MRP cluster
CC-N-103 Poor Poor NAL 1068 CC ST828 III
CC-N-16 Poor Moderate NAL 1068 CC ST828 I
CC-M-58 Non N/A AZI, GEN, TEL, CLI 902 CC ST828 II
CC-M-113 Poor Non CIP, TET, NAL, TEL 1068 CC ST828 IV
CC-S-79 Non N/A CIP, TET, NAL, TEL 1068 CC ST828 II
CC-S-44 Non N/A CIP, TET, NAL, TEL 1068 CC ST828 II
CC-S-66 Poor Poor CIP, TET, TEL 1068 CC ST828 II
CC-S-52 Poor Moderate AZI, ERY, GEN, FFN, TEL, CLI 2501 CC ST828 II
CC-S-10 Moderate Moderate- high AZI, ERY, GEN, TET, TEL, CLI 5372 CC ST828 I
CC-S-110 Poor Moderate- high CIP, TET, NAL 4933 CC ST828 IV
CC-E-95 Poor Poor AZI, ERY, GEN, TET, FFN, NAL, TEL, CLI 1110 CC ST828 III
CC-E-19 Poor Non AZI, ERY, GEN, CLI 1068 CC ST828 I
aClassification index: High= higher or comparable to C. jejuni 81-176. Moderate-High: Significantly lower than C. jejuni 81-176 but significantly higher than moderate.
Moderate: Significantly higher than C. jejuni NCTC11168. Poor: significantly lower or comparable to C. jejuni NCTC11168.
doi:10.1371/journal.pone.0025778.t004
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associated Campylobacter in the USA can potentially resist front-line
therapeutic drugs for treating human infections. For example,
31.8% and 44% of C. coli collected from calves and feedlot cattle
were resistant to erythromycin and ciprofloxacin, respectively [31].
Additionally, 47.7% and 49.1% of C. jejuni isolated from dairy and
feedlot cattle, respectively, were resistant to tetracycline [25,42]. In
agreement with these studies, our antibiotic resistance analysis
showed that a high percentage of the cattle-associated strains were
resistant to erythromycin, ciprofloxacin, tetracycline and others
(Fig 2A and Table 2). Remarkably, 23.7% and 12.1% of the cattle-
associated C. jejuni that were analyzed in our study exhibited
resistance to ciprofloxacin and erythromycin, respectively (Fig. 2A).
This was an important and marked difference when compared to
previous studies in the US that reported a relatively lower
frequency of resistance to ciprofloxacin (1.8% to 5%) and
erythromycin (0.4% to 2.9%) in C. jejuni isolated from different
cattle operations [25,31,42]. Our data further support previous
findings and predictions that livestock-associated Campylobacter are
becoming increasingly resistant to important antibiotics [41,43].
These observations highlight the need for rigorous surveillance of
antibiotics used in cattle operations in order to facilitate
interventions and curb further emergence of antibiotic resistant
Campylobacter.
Understanding the contributions of cattle to human infections
with Campylobacter relies heavily on: i) assessing the relationship
between the cattle-associated Campylobacter and those isolated from-
or previously implicated in human infections and ii) directly
examining the potential of these isolates to invade and persist in
the human intestine. However, these two criteria were rarely
investigated together in previous research that focused on cattle-
associated Campylobacter and are, to our knowledge, absent in
similar studies conducted in the USA. To meet the aforemen-
tioned criteria, we typed a pool of the cattle-associated
Campylobacter using MLST and further analyzed a subset of isolates
for their properties in an in vitro surrogate for the human host (i.e.
INT407 intestinal cell line). Since interpretation of the MLST
typing depends on pre-existing online data bases (PubMLST) to
assign sequence types (STs) to the isolates, it is possible to compare
the cattle-associated Campylobacter from this study to others from
different sources (e.g. humans) and locations, including other
countries. Subsequently, our MLST analysis confirmed that cattle-
associated C. jejuni (n=62) were diverse and belonged to disparate
STs (n=25; Table 3), while only 8 STs were assigned to C. coli
(n=50) (Table 3). Furthermore, we identified 12 C. jejuni that
belonged to unassigned clonal complexes (n=10), which along
with newly discovered alleles (n=3) and STs (n=13) (Table 3)
emphasize the genetic diversity of this bacterium in cattle, possibly
indicating that certain C. jejuni might be highly associated with this
potential source of infection. The latter is supported by reports
showing that CC ST-21 and ST-61 were predominant in cattle
samples from other countries, including the UK, Canada, New
Zealand, and Finland [9,33,44,45]. The detection of CC ST-61
and CC ST-21 (Table 3) in this study was of particular interest,
since these complexes constitute two of six CCs that harbor 60%
of C. jejuni associated with human disease [20,37]. Although all
tested cattle-associated C. jejuni were capable of invading the
human INT407 cells with variable efficiency, two isolate (Cj-M-13)
and (Cj-N-33) that belong to CC ST-21 not only exhibited an
invasive potential that was comparable to the hyper-invasive strain
C. jejuni 81–176 [46] but also showed a higher capability to survive
in the intracellular milieu (Fig. 3). Furthermore, these two isolates
were resistant to 7 out of 9 tested antimicrobials, including
ciprofloxacin, erythromycin, and gentamicin (Table 4). Along the
same lines, 11 out of 19 C. jejuni with varying invasive capacities
were able to either match or outperform the intracellular survival
potential of C. jejuni 81–176 (Fig. 3). No specific association was
observed with either invasion or intracellular survival of the tested
C. jejuni isolates and their MRPs, antimicrobial resistance
properties or their geographical distributions. Since many of the
tested C. jejuni (13 out of 19) were moderate to highly invasive
(Table 4) and given this bacterium’s aforementioned capability for
natural transformation, the occurrence of invasive strains in a
reservoir that is witnessing a rise in antibiotic-resistant Campylo-
bacter constitutes a cause for caution and increased surveillance.
Since invasion and intracellular survival of pathogens facilitates
evading the immune system of the host and allows for persistent
and recurrent infection [47], it can be argued that the cattle-
associated C. jejuni would pose a plausible risk to human health.
Furthermore, MLST data and invasion studies also showed
relatively lower clinical relevance of selected cattle-associated C.
coli isolates, which all belonged to CC ST-828, a complex that
include strains which are mainly isolated from agricultural and
environmental sources and some from clinical cases [48].
Although the invasion and intracellular survival capacities of C.
coli were overall lower than those of C. jejuni, one cattle associated
C. coli (CC-S-10) invaded the cells with approximately 10
4 CFU
per ml, while also surviving inside the cells in relatively high
numbers (Fig. 4). Taken together, our data confirm the
observations of Sheppard et al. [48] that ruminants also are
among the most likely sources of human infections with C. coli.
We conclude that cattle in the USA constitute a suitable niche
for the persistence of Campylobacter and a potentially important
source for human infections with these pathogens. The potential of
cattle-associated Campylobacter to resist antibiotics, invade and
persist in human cells, and their genetic classification into clinically
important clonal complexes warrant highlighting the contribution
of cattle to the epidemiology of these pathogens in the USA.
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